Connecting medical imaging leaders to the latest industry news, best practices, and AHRA happenings.
By Adrienne Dresevic, Esq. and Arturo Trafny, Esq. of The Health Law Partners, P.C.
Recently, both the Centers for Medicare & Medicaid Services (CMS) and the Department of Health and Human Services Office of Inspector General (OIG) have announced that they will be taking certain actions to minimize the burdens imposed on providers and suppliers by the 2019 Novel Coronavirus (COVID-19).
By Capitol Associates, Inc.
Deborah Brix, one of the top coronavirus response advisors to President Trump and Vice President Pence, is asking colleges and universities to develop a special type of blood test to see if healthcare workers have developed an immunity to COVID-19. The enzyme-linked immunosorbent assay (ELISA) tests can detect antibodies that the body naturally produce. These tests are already used to detect antibodies for other infectious diseases such as HIV.
By Capitol Associates, Inc.
President Trump issued a forceful warning about the danger posed by the coronavirus. His warning stated that anywhere from 100,000 to 240,000 people could die from COVID-19. The White House is trying to prepare the public for more tragic news that is expected throughout April as the number of cases and deaths is expected to increase – perhaps to a peak.
By Capitol Associates, Inc.
The House Energy and Commerce (E&C) Committee hopes to include its bill to address unexpected out-of-network (OON) “surprise” medical bills in the next big coronavirus relief bill.
By Capitol Associates, Inc.
House Speaker Nancy Pelosi (D-CA) has indeed confirmed that the House is already discussing its next major piece of legislation to help the country respond to the coronavirus public health emergency (PHE). Speaker Pelosi and other legislators from both the House and Senate are already describing what they hope to include in the “Phase IV” bill.
